Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry|October 2, 2025
The epigenetic landscape of kinetoplastid parasites: From histone post-translational modifications to emerging therapeutic strategiesInès Jacquet, Romain Paoli-Lombardo, Patrice Vanelle, et al.
The Journal of Organic Chemistry|March 8, 2022
Addition of Benzyl Halides to Aldehydes and Imines Using Photoactivated TDAE: Access to 3,4-Dihydroisocoumarins, 1,2-Diarylethanols, and 1,2-Diarylcarbamates under Metal-Free ConditionsCédric Spitz, Morgane Bertrand, Vincent Remusat, et al.
Journal of Educational Evaluation for Health Professions|July 16, 2019
Development and evaluation of an elective course of pharmacist's roles in disaster management in FranceMarc Montana, Fanny Mathias, Pascal Rathelot, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 21, 2013
Efficacy and toxicity of factor Xa inhibitorsMaryna Bondarenko, Christophe Curti, Marc Montana, et al.
European Journal of Medicinal Chemistry|November 27, 2009
TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agentsThierry Juspin, Michèle Laget, Thierry Terme, et al.
Molecules (Basel, Switzerland)|July 15, 2017
Metal-Free Regiodivergent Addition of Carbon Nucleophiles to α,β-Unsaturated ElectrophilesCédric Spitz, Alain G Giuglio-Tonolo, Thierry Terme, et al.
Molecules (Basel, Switzerland)|March 13, 2014
Synthesis of novel highly functionalized 4-thiazolidinone derivatives from 4-phenyl-3-thiosemicarbazonesAbdelmadjid Benmohammed, Omar Khoumeri, Ayada Djafri, et al.
Molecules (Basel, Switzerland)|November 17, 2007
Synthesis of new potentially bioactive bicyclic 2-pyridonesMaxime D Crozet, Pascal George, Michel P Crozet, et al.
Targeted Oncology|July 30, 2020
Antibody-Drug Conjugates in Thoracic Malignancies: Clinical Trials Reveal Both Promise and ChallengesSandrine Payan, Marc Montana, Christophe Curti, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
From the "One-Molecule, One-Target, One-Disease" Concept towards Looking for Multi-Target Therapeutics for Treating Non-Polio Enterovirus (NPEV) InfectionsHugo Roux, Franck Touret, Pascal Rathelot, et al.
Pageof 16